RxSense’s SingleCare Prescription Care Partners with DrOwl

DrOwl, a patented, HIPAA-compliant platform enabling users to access, understand and share their medical records, recently partnered with SingleCare. 

Through this partnership, DrOwl users will have access to free and convenient access to savings of up to 80% on their medications through integration with SingleCare, the companies said. 

 DrOwl, which was created to aid users in easily accessing their medical information, will now provide customers with information on their prescriptions, real-time pricing and provide savings on more than 10,000 medications at nearby pharmacies. 

RxSense® is a healthcare technology company developing industry-leading solutions that improve transparency and access to more affordable medications for millions across America. RxSense’s:

  • SingleCare® is a free prescription savings service available through its mobile app or discount cards available on Singlecare.com that can save consumers up to 80% on their prescriptions.
  • FamilyWize®is a prescription savings service that partners with some of the most respected community groups and healthcare providers in the country, including United Way Worldwide and the American Heart Association.

SingleCare’s prescription discount card is accepted at the nation’s largest pharmacies and grocers, including CVS, Walgreens, Walmart, Kroger, Albertsons, Safeway, Rite Aid and Meijer. 

The DrOwl app is a free platform that enables users to securely access, understand and share their medical records. Users sync their medical information to DrOwl and get a customized Patient Portal with information about their specific conditions, medications and allergies.

Medical records are often presented in clinical terms, which can be confusing for patients. DrOwl provides a custom searchable portal that includes information curated by medical professionals and customized for the user, in easy-to-understand language, the company said. 


Takeaway: DrOwl and RxSense look to empower their customers by providing price transparency and access to lower-cost prescriptions